Analysts Forecast Major Stock Gains in 2025
TL;DR Summary
Oppenheimer's chief investment strategist, John Stoltzfus, predicts continued market growth into 2025, with the S&P 500 potentially reaching 7100. The firm highlights two 'Strong Buy' stocks with significant growth potential: Sagimet Biosciences and Y-mAbs Therapeutics. Sagimet is advancing its fatty acid synthase inhibitors for conditions like MASH and acne, while Y-mAbs is developing its SADA platform for targeted cancer therapies. Both companies have received positive analyst ratings, with Sagimet potentially seeing a 583% increase and Y-mAbs a 144% rise.
- Oppenheimer Predicts Up to ~580% Jump for These 2 ‘Strong Buy’ Stocks TipRanks
- Tom Lee, who nailed 2024’s rally, is out with his 2025 outlook. What he sees next CNBC
- Stock Market Soared in 2024. What to Expect in 2025. Barron's
- Here's How Much Wall Street Expects Stocks To Rise in 2025 Investopedia
- Industry Analysts Predict the S&P 500 Will Close Above 6,600 in 2025 FactSet Insight
Reading Insights
Total Reads
0
Unique Readers
1
Time Saved
7 min
vs 8 min read
Condensed
94%
1,432 → 79 words
Want the full story? Read the original article
Read on TipRanks